4.2 Article

Atypical Familial Mediterranean Fever Presenting with Recurrent Upper Back Pain: A Case Report

期刊

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
卷 260, 期 2, 页码 165-169

出版社

TOHOKU UNIV MEDICAL PRESS
DOI: 10.1620/tjem.2023.J030

关键词

atypical arthritis; biologic; canakinumab; familial Mediterranean fever

向作者/读者索取更多资源

Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease characterized by recurrent episodes of fever, serositis, and synovitis. The synovitis attacks in FMF present as acute monoarthritis with pain and hydrarthrosis, which resolve spontaneously. Colchicine is effective in preventing these painful arthritis attacks in FMF, but distinguishing them from other febrile attacks with various clinical manifestations is crucial.
Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease that is characterized by recurrent episodes of fever, serositis, and synovitis. FMF synovitis attacks resemble the clinical presentation of acute monoarthritis with pain and hydrarthrosis, which always resolve spontaneously. In most cases, colchicine will prevent these painful arthritis attacks in FMF. However, distinguishing these arthritis episodes from other febrile attacks with various clinical manifestations, including serositis, is important. We describe a Japanese patient with FMF who presented a febrile attack with severe abdominal and upper back pain (peri-scapula lesion), without any other joint involvement. A 44-year-old female patient presented with recurrent episodes of fever with abdominal and back pain. She carried heterozygous variants in exon 3 of the MEFV gene (P369S/R408Q). She was diagnosed with FMF according to Tel-Hashomer's diagnostic criteria for FMF. Colchicine treatment improved her febrile attcks with peritonitis, however, severe back pain was sustained. This unique aspect of severe pain attack was successfully resolved by canakinumab treatment, which is a specific interleukin-1 & beta; monoclonal antibody, and was finally diagnosed as FMF-related shoulder joint synovitis. Further investigations were needed to evaluate the effectiveness of interleukin-1 antagonists against colchicine-resistant arthritis in FMF patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据